Trial Profile
A phase III trial of Apremilast in ulcerative colitis
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 11 Jan 2018
Price :
$35
*
At a glance
- Drugs Apremilast (Primary)
- Indications Ulcerative colitis
- Focus Registrational; Therapeutic Use
- 11 Jan 2018 New trial record
- 08 Jan 2018 According to a Celgene Corporation media release, the company expects to initiate this trial in 2018.